Prof. Ahmadreza Jamshidi | Radiology | Best Researcher Award
clinician | Tehran University of Medical Sciences | Iran
Prof. Ahmad Reza Jamshidi is a distinguished Professor of Rheumatology at Tehran University of Medical Sciences, renowned for his leadership in rheumatology research and education. Serving as Head of the Rheumatology Research Center and President of the Iranian Rheumatology Association, he has advanced understanding in seronegative spondyloarthropathies, rheumatoid arthritis, and connective tissue diseases. He actively contributes to international committees, editorial boards, and scientific societies, influencing global rheumatology practice. His extensive teaching experience spans medical students to subspecialty fellows, while his research outputs have earned high citations and recognition, positioning him among Iran’s most respected rheumatology scholars and clinical leaders.
Professional Profile
Google Scholar
Education
Prof. Jamshidi completed his medical degree at Tehran University of Medical Sciences, followed by specialized training in Internal Medicine at Shariati Hospital, earning the National Board certification. He pursued subspecialty training in Rheumatology at the Rheumatology Research Center, Tehran University, achieving the National Board of Rheumatology. Rising through academic ranks, he attained professorship, combining clinical expertise with research leadership. His education also encompassed advanced procedural skills, including synovial aspiration and biopsy techniques. His formative training shaped a career dedicated to patient care, medical education, and high-impact research, setting a strong foundation for leadership roles in national and international rheumatology networks.
Experience
Prof. Jamshidi’s career spans decades of clinical, research, and administrative excellence. He heads the Internal Medicine Research Committee, Internal Medicine Group at Shariati Hospital, Seronegative Research Unit, and Rheumatology Research Center. Internationally, he contributes to APLAR and ILAR committees. He has served on editorial boards for multiple medical journals and as a reviewer for prestigious rheumatology publications. His clinical practice covers inpatient and outpatient rheumatology care, connective tissue diseases, and specialized procedures. His administrative leadership and academic influence extend to guiding national rheumatology policy, fostering multidisciplinary research, and mentoring future specialists, reinforcing his impact on Iran’s medical and scientific landscape.
Research Interests
Prof. Jamshidi’s research focuses on seronegative spondyloarthropathies, low back pain, rheumatoid arthritis, and connective tissue diseases. His work integrates epidemiological studies, genetic research, and clinical trials to improve diagnosis, treatment, and prevention strategies. He has led WHO-ILAR COPCORD studies in Iran, contributing valuable data on the prevalence and risk factors of rheumatic diseases. His interests extend to understanding epigenetic mechanisms in autoimmune disorders, aiming to translate molecular findings into clinical applications. He also investigates the influence of lifestyle and environmental factors on musculoskeletal health, bridging basic science with public health interventions to enhance patient outcomes and quality of life.
Awards
Prof. Jamshidi’s outstanding contributions to rheumatology have earned him national and international recognition. As President of the Iranian Rheumatology Association and an associate member of the Iranian Academy of Medical Sciences, he has been honored for his leadership, research excellence, and dedication to medical education. His publications in high-impact journals have garnered significant citations, reflecting his influence in advancing rheumatology knowledge globally. Through his pioneering work in epidemiology, clinical trials, and genetic studies, he has shaped best practices in rheumatic disease management. These achievements underscore his role as a leading figure in academic medicine and healthcare innovation.
Top Noted Publications
Title: The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
Year: 2014
Cited by: 1144
Title: Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Year: 2020
Cited by: 472
Title: WHO-ILAR COPCORD study (stage 1, urban study) in Iran
Year: 2008
Cited by: 397
Title: Low back pain education and short term quality of life: a randomized trial
Year: 2007
Cited by: 263
Title: Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review
Year: 2019
Cited by: 227
Conclusion